MAPT rs12967135: What Your Genotype Means
The rs12967135 variant is a genetic marker located within the MAPT gene region on chromosome 17. It is recognized as a lead variant associated with the 17q21.31 inversion locus, which has been linked in some studies to restless legs syndrome and variations in sleep health scores.
What each genotype means
Typical MAPT locus profile
This genotype represents the most common configuration at this position within the MAPT gene region. Research indicates this locus is part of a larger structural inversion on chromosome 17q21.31, which has been statistically associated with variations in sleep health and restless legs syndrome risk in European populations. This association is considered limited, and these findings reflect population-level trends rather than individual clinical outcomes.
Carried by the majority of individuals of European ancestry, consistent with a major allele frequency of approximately 75-80%.
Heterozygous MAPT variant carrier
You carry one copy of the variant allele associated with the 17q21.31 inversion locus. Studies suggest this specific genetic region may influence sleep quality and susceptibility to restless legs syndrome, though the evidence remains limited and complex. Because this is a common genetic variation, it is not considered a diagnostic marker; please discuss any concerns regarding sleep health with your healthcare provider.
Carried by roughly 1 in 3 people of European ancestry, reflecting the common nature of this variant in these populations.
Variant-associated MAPT profile
You carry two copies of the variant allele at this MAPT locus. This genotype is linked to the 17q21.31 inversion, which has been identified in large-scale studies as a factor potentially influencing sleep health and restless legs syndrome risk. The clinical significance of this association is currently limited, and it is important to remember that many factors contribute to sleep health beyond this single genetic marker.
Carried by approximately 1 in 16 to 1 in 20 people of European ancestry, based on a minor allele frequency of roughly 20-25%.
Understanding the Variant and Its Location
The rs12967135 variant is situated on chromosome 17 at the 17q21.31 locus. This specific region of the human genome is notable for a large, common inversion polymorphism. An inversion occurs when a segment of DNA breaks and reattaches in the reverse orientation. Because this region is structurally complex and evolutionarily dynamic, it often contains multiple variants that are inherited together as a block, known as a haplotype. The rs12967135 SNP serves as a marker for this broader structural variation. Researchers track such variants to understand how the architecture of our chromosomes influences biological traits. Because this region is so complex, scientists often study it to see how these structural differences might affect gene regulation or the physical expression of traits across different populations.
The Role of the MAPT Gene
The MAPT gene provides instructions for making a protein called tau. Tau proteins are primarily found in neurons, where they play a critical role in stabilizing microtubules—the internal structural supports that help cells maintain their shape and transport nutrients. In the brain, the proper function of tau is essential for healthy neuronal communication. The 17q21.31 region, where MAPT resides, is known to influence the expression levels of this protein. Research has indicated that different versions of this chromosomal region, often categorized as H1 and H2 haplotypes, can lead to variations in how much tau protein is produced in brain tissue. While tau is most famously studied in the context of neurodegenerative conditions, its role in general neurological health and sleep regulation remains an active area of scientific investigation.
Research Associations and Evidence Strength
Current research has identified associations between the 17q21.31 locus and sleep-related traits, including restless legs syndrome (RLS). RLS is a chronic movement disorder characterized by an irresistible urge to move the legs, often worsening during periods of rest. While genome-wide association studies have highlighted this locus in European cohorts, the evidence strength for rs12967135 specifically remains limited. It is important to note that genetic associations are statistical observations made across large groups of people; they do not imply a direct cause-and-effect relationship for any single individual. Furthermore, many factors contribute to sleep health, including environmental, lifestyle, and other genetic influences. Because the evidence is currently limited, these findings should be viewed as preliminary insights into the complex genetic architecture of sleep rather than diagnostic indicators.
Population Frequency and Interpretation
The rs12967135 variant is relatively common, with a minor allele frequency reported at approximately 20-25% in European populations. Genetic frequency can vary significantly depending on ancestral background, and it is common for variants to be more prevalent in some groups than others. When interpreting this information, it is essential to remember that having a specific genotype does not determine one's health outcomes. Genetic data provides a snapshot of biological variation, but it does not account for the myriad of external factors that shape human health. Readers should avoid using this information to make assumptions about their own health or to guide medical decisions. If you have concerns about sleep quality or symptoms of restless legs syndrome, the most appropriate step is to consult with a qualified healthcare professional who can provide a comprehensive evaluation.
How common is this variant?
The minor allele frequency for rs12967135 is approximately 20-25% in European populations, making it a relatively common variant in these groups.
Frequently asked questions
Is rs12967135 a diagnostic test for restless legs syndrome?
No, rs12967135 is not a diagnostic test. Restless legs syndrome is a clinical diagnosis made by a healthcare provider based on symptoms and medical history, not by genetic testing.
Can I use this information to change my medication?
No. You should never change or stop any medication based on genetic information. Always discuss your medications and any health concerns with your clinician or pharmacist.
What does it mean if I have the minor allele?
Having a specific allele simply means you carry a common variation in your DNA. It does not guarantee that you will develop any specific condition or trait.
Why is the 17q21.31 region considered complex?
This region is considered complex because it contains a large inversion polymorphism and segmental duplications. These structural features make it difficult to study and can influence the expression of multiple nearby genes.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12967135?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29